SOLASIA PHARMA K.K. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27 JPY | 0.00% |
|
0.00% | -40.00% |
Solasia Pharma K.K. is a Japan-based pharmaceutical company. The Company is mainly engaged in the development, sale, importing and exporting of pharmaceutical products targeting commercialization in Japan, China and other Asian countries. It focuses on commercializing assets in the oncology/hematology field, by developing products licensed from western pharmaceutical and biotech companies. The Company's main products include SP-01 Granisetron Transdermal Delivery System (Sancuso), SP-02 Darinaparsin (Zinapar, ZIO-101, and SP-03 Oral Medical Device (episil oral liquid).
Sector
Pharmaceuticals
Calendar
2024-05-14
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
27
JPY
Average target price
100
JPY
Spread / Average Target
+270.37%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -40.00% | 31.53M | |
| -2.61% | 89.08B | |
| +3.55% | 40.9B | |
| -14.40% | 32.25B | |
| +55.89% | 25.14B | |
| -15.96% | 15.39B | |
| -15.50% | 11.91B | |
| -41.29% | 11.89B | |
| -11.75% | 11.64B | |
| +7.87% | 9.03B |
- Stock Market
- Equities
- 4597 Stock
- Funds and ETFs Solasia Pharma K.K.